Reports for EMTRICITABINE
Ingredient
EMTRICITABINE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AURO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Actual shortage | 2024-03-27 | 2024-04-29 | 223603 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Avoided shortage | 2017-09-22 | 2018-12-19 | 23172 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Avoided shortage | 2020-05-06 | 2020-05-12 | 114152 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-04-29 | 2020-07-09 | 113424 |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-12-07 | 2021-02-03 | 129766 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-01-02 | 2019-03-29 | 70748 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-04-03 | 2019-04-23 | 80423 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-04-23 | 2019-06-26 | 82201 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-03 | 2019-07-10 | 88291 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-29 | 2019-09-26 | 90113 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
Showing 1 to 1 of 1